The Journal of the Association of Physicians of India · 2018
Familial Hypercholesterolemia (FH) Awareness Amongst Physicians in Mumbai, India.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Reddy Lakshmi Lavanya, Ashavaid Tester F
Аннотация
BACKGROUND: Familial Hypercholesterolemia (FH) is a common genetic disorder affecting low density lipoprotein cholesterol (LDL-C) metabolism. Prolong exposure to elevated LDL-C results in the development of atherosclerotic lesions and a substantially increased risk of Coronary Artery Disease (CAD). In contrast, early detection and effective treatment of FH can result in a significant improvement in clinical outcomes. Despite these data, FH remains largely underdiagnosed and untreated.
OBJECTIVE: To assess the awareness, knowledge, and clinical practices of FH by General Physicians (GPs) in Mumbai.
METHODS: Physicians were requested to complete a survey comprising Multiple Choice questions (MCQs) on FH. The questionnaire inquired about; familiarity and awareness of the disorder, clinical description, prevalence, inheritance and their opinions on FH clinical services.
RESULTS: Of the 79 GPs surveyed, 31% of them correctly described FH and only 28% knew about its prevalence. 51% perceived themselves to have an above moderate familiarity with this disorder. 46% of them were aware of the risk of cardiovascular disease (CVD) associated with FH. 80% of GPs were unsure or unaware of whether they had FH patients under their care. 50% and 33% of physicians identified statins as monotherapy and statin & ezetimibe as a combination therapy for FH respectively.
CONCLUSION AND INTERPRETATION: Immediate attention should be focused on increasing awareness and knowledge about FH in India. Establishment of lipid clinic network will aid in improving care and clinical practices.
OBJECTIVE: To assess the awareness, knowledge, and clinical practices of FH by General Physicians (GPs) in Mumbai.
METHODS: Physicians were requested to complete a survey comprising Multiple Choice questions (MCQs) on FH. The questionnaire inquired about; familiarity and awareness of the disorder, clinical description, prevalence, inheritance and their opinions on FH clinical services.
RESULTS: Of the 79 GPs surveyed, 31% of them correctly described FH and only 28% knew about its prevalence. 51% perceived themselves to have an above moderate familiarity with this disorder. 46% of them were aware of the risk of cardiovascular disease (CVD) associated with FH. 80% of GPs were unsure or unaware of whether they had FH patients under their care. 50% and 33% of physicians identified statins as monotherapy and statin & ezetimibe as a combination therapy for FH respectively.
CONCLUSION AND INTERPRETATION: Immediate attention should be focused on increasing awareness and knowledge about FH in India. Establishment of lipid clinic network will aid in improving care and clinical practices.